Marcy Graham
Investor Relations Contact bei AADI BIOSCIENCE, INC.
Profil
Marcy Graham is a professional who currently works as Senior Vice President-IR & Communications at Aadi Bioscience, Inc. She previously worked as Director-Investor Relations & Communications at Sequenom, Inc. and as Executive Director-Investor Relations at Ambit Biosciences Corp.
She also held Senior Director-Investor Relations position at Genoptix, Inc. from 2007 to 2011.
Additionally, she worked as VP-Investor Relations & Corporate Communications at aTyr Pharma, Inc., Vice President-Investor Relations & Communications at Mirati Therapeutics, Inc., and Vice President-Corporate Affairs at Poseida Therapeutics, Inc. Ms. Graham received her undergraduate degree from The University of New Mexico and her MBA from Anderson School of Management.
Aktive Positionen von Marcy Graham
| Unternehmen | Position | Beginn |
|---|---|---|
| AADI BIOSCIENCE, INC. | Investor Relations Contact | 01.05.2022 |
Ehemalige bekannte Positionen von Marcy Graham
| Unternehmen | Position | Ende |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Investor Relations Contact | 01.01.2022 |
| AMBIT BIOSCIENCES CORP | Investor Relations Contact | 09.04.2015 |
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Public Communications Contact | 01.03.2011 |
| MIRATI THERAPEUTICS | Investor Relations Contact | - |
| ATYR PHARMA, INC. | Investor Relations Contact | - |
Ausbildung von Marcy Graham
| The University of New Mexico | Undergraduate Degree |
| Anderson School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| AADI BIOSCIENCE, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA. | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
